Skip to main content
Skip to content
Case File
efta-efta01454265DOJ Data Set 10Correspondence

EFTA Document EFTA01454265

Date
Unknown
Source
DOJ Data Set 10
Reference
efta-efta01454265
Pages
0
Persons
0
Integrity
Loading PDF viewer...

Summary

Ask AI About This Document

0Share
PostReddit

Extracted Text (OCR)

EFTA Disclosure
Text extracted via OCR from the original document. May contain errors from the scanning process.
From: jeffrey E. [[email protected]) Sent: 5/20/2014 9:41:53 AM To: Tazia Smith CC: Paul Morris ; Vinit Sahni ; Nav Gupta I I; Richard Kahn ; Vahe Stepanian Subject: Re: Long Equity: Consider $1mm Brookdale Senior Living on macro/micro tailwinds (- 30% upside to $42 tgt) IC) i want to play a stronger rupee 9 month horizon On Tue, May 20, 2014 at 9:33 AM, Tazia Smith <MMI wrote: Classification: Confidential Jeffrey - Focusing on listed/exchange traded opportunities: Consider buying $1-2mm position in Brookdale Senior Living (BKD) Macro Trend: Baby boomers retiring and aging population Micro: Merger tailwinds, pro-forma valuation upside and broader investor demand Brookdale Senior Living (BKD) Closed 5/19: $32.06 ($32.40 last) $3.8bn mkt cap (trades 1.3mm shs a day avg) $42 DB 12mo price target (implies -30% upside) vs. 37.71 cons (-16%) Catalyst: merger proxy filing expected this month (Brookdale bid to acquire Emeritus, ESC ($1.4bn mkt cap), in late Feb for $2.8bn in stock; est merger completion is 3Q14) Valuation: $42 = 12x proforma BKD+ESC 2015 CFFO/sh of $3.40 a. Strong Industry Fndamentals b. BKD's market leadership (10% pro forma market share and attractive national footprint + management team and corporate infrastructure lending itself to leverage/scale) c. Mid-teen's growth characteristics with organic 6-8% and accretion from the ESC acquisition adding 8-10% for the next 2-3 years (ests = +18% in 2015 and + 27% in 2016). Q1 earnings report no 5/8, BKD posted its third consecutive quarter of double digit CFFO growth d. Current Valuation: 9.1x pro-forma 2015 CFFO/sh and just shy of 10x on a stand alone basis (8.9x pro-forma 2015 EV/EBITDA, 11.6x stand-alone) e. Market Cap — pro-forma will be greater than $5bn, expected to deliver broader investor interest Key risks include: competition, new supply, capex requirements to upgrade Emeritus' portfolio, merger approvals, housing market, interest rate sensitivity CFFO = cash flow from operations https://qer.qm.cib.intranet.db.com/qer/document/pdf/0900b8c088436c25.pdf CONFIDENTIAL - PURSUANT TO FED. R. CRIM. P. 6(e) DB-SDNY-0 112268 CONFIDENTIAL SDNY_GM_00258452 EFTA01454265

Technical Artifacts (2)

View in Artifacts Browser

Email addresses, URLs, phone numbers, and other technical indicators extracted from this document.

URLhttps://qer.qm.cib.intranet.db.com/qer/document/pdf/0900b8c088436c25.pdf

Forum Discussions

This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.

Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.